Compare RNAC & RMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNAC | RMAX |
|---|---|---|
| Founded | 2007 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 163.3M | 167.9M |
| IPO Year | 2016 | 2013 |
| Metric | RNAC | RMAX |
|---|---|---|
| Price | $6.41 | $6.96 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | ★ $38.80 | $9.00 |
| AVG Volume (30 Days) | 92.7K | ★ 174.4K |
| Earning Date | 03-12-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.62 |
| Revenue | $1,091,000.00 | ★ $292,931,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.36 |
| P/E Ratio | ★ N/A | $11.48 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.98 | $6.90 |
| 52 Week High | $20.00 | $10.61 |
| Indicator | RNAC | RMAX |
|---|---|---|
| Relative Strength Index (RSI) | 37.62 | 35.86 |
| Support Level | $6.23 | $7.11 |
| Resistance Level | $6.60 | $7.79 |
| Average True Range (ATR) | 0.43 | 0.31 |
| MACD | -0.07 | -0.07 |
| Stochastic Oscillator | 16.02 | 15.69 |
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.